SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petrobras is drawing attention as traders position around Brazils presidential runoff, with bullish speculation that a Flvio Bolsonaro victory could improve shareholder policies or raise privatization prospects. Others warn that the outcome remains uncertain and that political intervention or a sell-the-news reaction could weigh on shares; higher oil prices are an additional supportive theme.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Reports that Papa Johns largest U.S. franchisee has joined Irth Capitals take-private bid have fueled renewed buyout speculation. Traders see the franchisees involvement as strengthening the proposal, while others remain skeptical amid the boards silence and unconfirmed talk of a higher offer.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Renewed Middle East tensions and disruptions around the Strait of Hormuz are driving discussion about oil supply and crude prices, with traders debating why PR sometimes lags oils moves. Some also point to strong operating results and higher production guidance as support for the company, while others remain wary of sharp swings tied to war and ceasefire headlines.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta Personals rollout and its payment and banking featuresincluding ACH capabilities and Visa Direct/Bivo Cash integrationsare driving attention, alongside expectations for partner adoption and network activity. Bulls see the launches as evidence of growing utility, while skeptics point to limited sustained usage and weak price action despite the announcements.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendus active community is promoting its expanding real-world brand and initiatives, including merchandise, food and drink products, sports events, and games, while encouraging holders to accumulate. The tone is overwhelmingly bullish and emphasizes community-building and reported price strength, though a few posts question the projects promotional claims.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

XLM is drawing attention for its persistent selloff and repeated difficulty holding the 20-cent level, with traders split between buying the dip and criticizing the tokens weak price action. Bulls point to Stellars real-world-asset tokenization and anticipated institutional use, including DTCC-related developments, while skeptics argue adoption may not translate into demand for XLM given its tokenomics.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

COMPs sharp, volatile price action is drawing attention, with traders split between calling a bottom and buying the dip versus criticizing its weak performance and warning of further declines. Bullish posts often point to its capped supply and Compounds institutional and DeFi plans, while others say the token is lagging the broader crypto market.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

FDA approval to expand Alpha Taus U.S. REGAIN trial in recurrent glioblastoma from 10 to 20 patients is the main catalyst, alongside anticipated clinical data presentations and readouts. Traders are broadly bullish on the trials early results and the wider pipeline, though the GBM evidence remains preliminary and based on a small patient group.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is drawing attention after critical PHP vulnerabilities prompted urgent patching and exploit warnings; traders see its WAF protections as a potential beneficiary, alongside a broader cybersecurity-sector rally. The reaction is largely bullish, though some discussion frames the move as a short-term trade rather than proof of lasting demand.

Cash Cat

Cash Cat is drawing attention amid sharp, volatile price swings and repeated attempts to break through resistance. Bulls are buying dips and urging holders to stay in, while skeptics warn of a pump-and-dump and continued selling; short-squeeze, buyback, and utility claims remain speculative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt

ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallSt ARDX Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Ardelyx, Inc. Securities Class Action - Contact SueWallStPR NewswireNEW YORK, Oct. 22, 2026 Regulatory...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming...

ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice - Contact Levi & Korsinsky ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice - Contact Levi & KorsinskyPR NewswireNEW YORK, Oct. 21, 2026 Important Notice Regarding Alleged Payer Access and Reimbursement...

Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ARDX

Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ARDX Ardelyx, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - ARDXPR NewswireNEW YORK, Oct. 20, 2026 NEW YORK, Oct. 20, 2026 /PRNewswire/ -- The DJS Law...

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud LawsuitPR NewswireNEW YORK, Oct. 19, 2026 NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds...

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS LawPR NewswireLOS ANGELES, Oct. 19, 2026 LOS ANGELES, Oct. 19, 2026 /PRNewswire/ -- Schall, Brown & Schwartz...

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt

ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallSt ARDX Shareholder Alert: Ardelyx, Inc. Securities Class Action Lawsuit - Investors Should Contact SueWallStPR NewswireNEW YORK, Oct. 15, 2026Promise vs. Reality: Ardelyx pointed investors...

ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses

ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your Losses ARDX Stockholders Have Rights - If You Lost Money Investing in Ardelyx, Inc. Contact Robbins LLP for Information About Recovering Your LossesPR NewswireSAN...

ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline

ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action Deadline ARDX DEADLINE: Levi & Korsinsky Reminds Ardelyx, Inc. Investors of Upcoming Securities Class Action DeadlinePR NewswireNEW YORK, Oct. 14, 2026Alert: Claims focus on alleged...

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX Stock Tumbles As Xphozah Loses Final Medicare Reimbursement Battle  

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Xphozah is used to lower high phosphate levels in patients with chronic kidney disease who are on dialysis.</li><li>Being moved into the bundle typically reduces pricing power and can slow adoption by dialysis providers compared with separate reimbursement.</li><li>Jefferies noted that the appellate court decision effectively resolves the long-running legal challenge.</li></ul>Shares of Ardelyx (ARDX) fell 8% on Friday after a federal appellate court reaffirmed a lower court decision and dismissed the company’s appeal regarding its drug Xphozah not being eligible for separate reimbursement under Medicare.The stock clocked its worst day since late February on Friday.<h2 class="st-heading-2">Court Decision Ends Legal Challenge</h2>The ruling clears the way for Xphozah to be included in Medicare’s End-Stage Renal Disease (ESRD) bundled payment system. Under this system, dialysis centers receive a fixed payment that covers most services and medications for patients. As a result, Xphozah will no longer be reimbursed separately under Medicare Part D.The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle. As a result, the appeals court dismissed Ardelyx’s case and upheld the lower court’s ruling.Xphozah is used to lower high phosphate levels in patients with chronic kidney disease who are on dialysis. Being moved into the bundle typically reduces pricing power and can slow adoption by dialysis providers compared with separate reimbursement.<h2 class="st-heading-2">Jefferies View</h2>Jefferies noted that the appellate court decision this morning effectively resolves the long-running legal challenge. The firm had viewed the appeal as a “free call option” and said investors had not been heavily focused on it as a major catalyst.“The loss shouldn’t fundamentally change anything,” Jefferies wrote in a research note.However, the analyst flagged that second-quarter sales of Ardelyx’s other product, IBSRELA, are likely to come in below consensus estimates. With the Medicare appeal now behind the company, Jefferies said shares could face some near-term pressure. The firm maintained its ‘Buy’ rating and $15 price target on Ardelyx, representing a potential upside of about 170% from the last closing price.Ardelyx’s two main products are IBSRELA, which treats irritable bowel syndrome with constipation and has shown strong growth, and Xphozah. The company has continued to report revenue growth from both drugs despite the reimbursement uncertainty surrounding Xphozah.<h2 class="st-heading-2">How Did ARDX Retail Traders React?</h2>On Stocktwits, retail sentiment around ARDX stock jumped from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.“The court case always was a long (as in: loooooooong) shot. Today’s news shouldn’t change a thing,” a Stocktwits user said.<stembedurl>https://www.stocktwits.com/Burning_Cash/message/657650626</stembedurl>“Fingers crossed that Ardelyx focuses on execution from now on,” another user wrote.<stembedurl>https://www.stocktwits.com/opportoni/message/657611320</stembedurl><a href="https://stocktwits.com/symbol/ARDX">ARDX stock</a> has fallen 5% year-to-date.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/uncy-stock-on-track-for-worst-day-in-about-a-year-ahead-of-fda-decision-on-lead-drug/cZ1cy7NR7Wd">UNCY Stock On Track For Worst Day In About A Year Ahead Of FDA Decision On Lead Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Ardelyx logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

The U.S. Court of Appeals for the D.C. Circuit said federal law prevents judges from reviewing Medicare’s decision to include certain kidney drugs in the dialysis payment bundle.

Vanguard Total Stock Market ETF

SPDR S&P Biotech ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$3.08
Prev Close	$3.20
Open	$3.17
Dividend Yield	0.00%
50-Day Moving Average	$3.52
Beta	0.98
Avg. Volume	4.16M
PE Ratio	-13.62

52-Week High	$8.40
52-Week Low	$3.02
Market Capitalization	$767.5M
EPS (Annual)	-$0.2556
Price to Book	5.15
Revenue Per Employee	$832,965.23

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARDX Fundamentals